3.6 Administration of medications
Marked discrepancies between national guidelines [1] and recorded answers were reported. The most common treatment administered for bronchiolitis was high flow oxygen therapy (81.66%) followed by oxygen therapy with nasal cannula or face mask (68.05%), hypertonic solution (49.70%), inhaled short-acting beta-agonists (SABA) (39.64%), inhaled epinephrine (21.30%), an inhaled corticosteroid (ICS) (17.16%), systemic CS (64.52%), respiratory physiotherapy (8.88%), antibiotics (4.73%), intravenous SABA (0.59%). Among paediatricians using systemic CS, betamethasone was the most common CS administered (64.52%), followed by methylprednisone (16.66%), prednisolone (7.26%), beclometasone dipropionate (4.7%), and dexamethasone (4.7%). In line with national guidelines [1], only 16.66% of the participants did not administer systemic CS.